Open AccessCurrent representation of endovascular treatment of patients with left main coronary artery disease
Author(s) -
V. Yu Vlasov,
Власов В. Ю,
Б. А. Руденко,
Руденко Б. А,
А. S. Shanoyan,
S A Shanoian,
В.П. Мазаев,
Мазаев В. П,
А Ш Ахадова,
Ахадова А. Ш,
Ф. Б. Шукуров,
Шукуров Ф. Б
Publication year - 2016
Publication title -
cardiosomatika
Language(s) - English
Resource type - Journals
eISSN - 2658-5707
pISSN - 2221-7185
DOI - 10.26442/cs45264
Subject(s) - medicine , restenosis , cardiology , angioplasty , percutaneous , stent , bypass grafting , artery , coronary artery disease , lesion , left main coronary artery disease , gold standard (test) , surgery
Coronary artery bypass grafting (CABG) is known as the gold standard treatment of unprotected left main coronary artery (LMCA) disease and has the highest level of evidence in European and American recommendations. However development of endovascular methods of treatment, and first of all decrease of in-stent-restenosis allow us to consider angioplasty and stenting of LMCA as an alternative method to CABG. The comparative world analysis of results of percutaneous coronary interventions and CABG is provided in article. It tells also how efficiency of percutaneous coronary interventions depends on such factors as lesion localization, diabetes, type of drug-eluting stent.